Exact Mass: 305.1277

Exact Mass Matches: 305.1277

Found 16 metabolites which its exact mass value is equals to given mass value 305.1277, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Zaleplon

N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide

C17H15N5O (305.1277)


Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

6-[5-(4-Carbamimidoylphenyl)-2-furyl]pyridine-3-carboxamidine

6-[5-(4-carbamimidoylphenyl)furan-2-yl]pyridine-3-carboximidamide

C17H15N5O (305.1277)


   

Zaleplon

Zaleplon

C17H15N5O (305.1277)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

5-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-4-METHYL-1-(M-TOLYL)-1H-IMIDAZOL-2(3H)-ONE

5-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-4-METHYL-1-(M-TOLYL)-1H-IMIDAZOL-2(3H)-ONE

C17H15N5O (305.1277)


   

N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-(1,1,2,2,2-pentadeuterioethyl)acetamide

N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-(1,1,2,2,2-pentadeuterioethyl)acetamide

C17H15N5O (305.1277)


   

1-[5-(2-Benzyl-2H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

1-[5-(2-Benzyl-2H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

C17H15N5O (305.1277)


   

1-[5-(1-Benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

1-[5-(1-Benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine

C17H15N5O (305.1277)


   

6-Amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

6-Amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one

C17H15N5O (305.1277)


   

[(E)-(1,3-diphenylpyrazol-4-yl)methylideneamino]urea

[(E)-(1,3-diphenylpyrazol-4-yl)methylideneamino]urea

C17H15N5O (305.1277)


   

N-(2-furanylmethyl)-1-(phenylmethyl)-4-pyrazolo[3,4-d]pyrimidinamine

N-(2-furanylmethyl)-1-(phenylmethyl)-4-pyrazolo[3,4-d]pyrimidinamine

C17H15N5O (305.1277)


   

N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

C17H15N5O (305.1277)


   

7-(4-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

7-(4-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

C17H15N5O (305.1277)


   

7-(2-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

7-(2-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine

C17H15N5O (305.1277)


   

N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide

N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide

C17H15N5O (305.1277)


   

N-[(E)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]pyridine-4-carboxamide

N-[(E)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]pyridine-4-carboxamide

C17H15N5O (305.1277)


   

N-(2-aminophenyl)-2-anilino-5-pyrimidinecarboxamide

N-(2-aminophenyl)-2-anilino-5-pyrimidinecarboxamide

C17H15N5O (305.1277)